These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20096645)

  • 1. Early insulin sensitivity after restrictive bariatric surgery, inconsistency between HOMA-IR and steady-state plasma glucose levels.
    van Dielen FM; Nijhuis J; Rensen SS; Schaper NC; Wiebolt J; Koks A; Prakken FJ; Buurman WA; Greve JW
    Surg Obes Relat Dis; 2010; 6(4):340-4. PubMed ID: 20096645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comment on: insulin sensitivity during first months after restrictive bariatric surgery, inconsistency between HOMA-IR and steady-state plasma glucose levels.
    Ikramuddin S
    Surg Obes Relat Dis; 2010; 6(4):345-6. PubMed ID: 20627711
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity.
    Schernthaner GH; Kopp HP; Kriwanek S; Krzyzanowska K; Satler M; Koppensteiner R; Schernthaner G
    Obes Surg; 2006 Jun; 16(6):709-15. PubMed ID: 16756729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery.
    Schernthaner GH; Kopp HP; Krzyzanowska K; Kriwanek S; Koppensteiner R; Schernthaner G
    Eur J Clin Invest; 2006 Jun; 36(6):395-401. PubMed ID: 16684123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bariatric surgery in obesity: changes of glucose and lipid metabolism correlate with changes of fat mass.
    Frige' F; Laneri M; Veronelli A; Folli F; Paganelli M; Vedani P; Marchi M; Noe' D; Ventura P; Opocher E; Pontiroli AE
    Nutr Metab Cardiovasc Dis; 2009 Mar; 19(3):198-204. PubMed ID: 18684601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of weight loss on insulin resistance in surgically treated obese patients.
    Muscelli E; Mingrone G; Camastra S; Manco M; Pereira JA; Pareja JC; Ferrannini E
    Am J Med; 2005 Jan; 118(1):51-7. PubMed ID: 15639210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term effect of weight loss through restrictive bariatric surgery on serum levels of vaspin in morbidly obese subjects.
    Golpaie A; Tajik N; Masoudkabir F; Karbaschian Z; Talebpour M; Hoseini M; Hosseinzadeh-Attar MJ
    Eur Cytokine Netw; 2011 Dec; 22(4):181-6. PubMed ID: 22266100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increase in visfatin after weight loss induced by gastroplastic surgery.
    Krzyzanowska K; Mittermayer F; Krugluger W; Kopp HP; Schernthaner G
    Obesity (Silver Spring); 2006 Nov; 14(11):1886-9. PubMed ID: 17135602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of androgens to insulin resistance and chronic inflammation in morbidly obese premenopausal women: studies before and after vertical banded gastroplasty.
    Kopp HP; Krzyzanowska K; Schernthaner GH; Kriwanek S; Schernthaner G
    Obes Surg; 2006 Sep; 16(9):1214-20. PubMed ID: 16989707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery.
    Pereira JA; Lazarin MA; Pareja JC; de Souza A; Muscelli E
    Obes Res; 2003 Dec; 11(12):1495-501. PubMed ID: 14694214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in insulin resistance following bariatric surgery: role of caloric restriction and weight loss.
    Gumbs AA; Modlin IM; Ballantyne GH
    Obes Surg; 2005 Apr; 15(4):462-73. PubMed ID: 15946423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in circulating glucose, insulin and leptin levels and improvement in insulin resistance at 1 and 3 months after gastric bypass.
    Ramos AP; de Abreu MR; Vendramini RC; Brunetti IL; Pepato MT
    Obes Surg; 2006 Oct; 16(10):1359-64. PubMed ID: 17059747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity.
    McLaughlin T; Abbasi F; Lamendola C; Kim HS; Reaven GM
    Metabolism; 2001 Jul; 50(7):819-24. PubMed ID: 11436188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The soluble form of the receptor of advanced glycation endproducts increases after bariatric surgery in morbid obesity.
    Brix JM; Höllerl F; Kopp HP; Schernthaner GH; Schernthaner G
    Int J Obes (Lond); 2012 Nov; 36(11):1412-7. PubMed ID: 22828946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a rapid weight loss induced by laparoscopic adjustable gastric banding on arterial stiffness, metabolic and inflammatory parameters in patients with morbid obesity.
    Shargorodsky M; Fleed A; Boaz M; Gavish D; Zimlichman R
    Int J Obes (Lond); 2006 Nov; 30(11):1632-8. PubMed ID: 16552402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects.
    Valverde I; Puente J; Martín-Duce A; Molina L; Lozano O; Sancho V; Malaisse WJ; Villanueva-Peñacarrillo ML
    Obes Surg; 2005 Mar; 15(3):387-97. PubMed ID: 15826475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid profile in the severely obese: changes with weight loss after lap-band surgery.
    Dixon JB; O'Brien PE
    Obes Res; 2002 Sep; 10(9):903-10. PubMed ID: 12226139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fasting serum insulin and the homeostasis model of insulin resistance (HOMA-IR) in the monitoring of lifestyle interventions in obese persons.
    Vogeser M; König D; Frey I; Predel HG; Parhofer KG; Berg A
    Clin Biochem; 2007 Sep; 40(13-14):964-8. PubMed ID: 17583689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial activation markers and their key regulators after restrictive bariatric surgery.
    Nijhuis J; van Dielen FM; Fouraschen SM; van den Broek MA; Rensen SS; Buurman WA; Greve JW
    Obesity (Silver Spring); 2007 Jun; 15(6):1395-9. PubMed ID: 17557976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.